Netherlands· NL-677ad742b877
Brietal Hikma, poeder voor injectievloeistof 500 mg
A methohexital product containing methohexital natrium, registered in Netherlands by Hikma Farmaceutica (Portugal), S.A.. The same ATC class is registered in 2 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Methohexital is registered in 2 of 19 countries.
Countries holding a registration under ATC N01AF01 (methohexital), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 1 of them publish a price we can compare per daily dose
Methohexital · ATC N01AF01
2 / 19 countries
- Finlandprice
- Netherlands
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- METHOHEXITAL NATRIUM
- Manufacturer
- Hikma Farmaceutica (Portugal), S.A.
- Country
- Netherlands (NL)
- ATC code
- N01AF01
- ATC class
- Methohexital
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id00544
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
31 interactions on record for methohexital.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methohexital · interactions on record
31 records
- 5 severe
- 21 moderate
- 5 minor
Most severe, free to view
- WarfarinB01AA03severe
- EthanolB05XX04severe
- EthanolV03AB16severe
- EthanolV03AZ01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methohexital in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBrevital SodiumPar Health USA, LLC
- GermanyBrevimytalHikma Farmacêutica (Portugal), S.A.
- FinlandBrietalEli Lilly Finland Oy Ab
- United KingdomBrevital Sodium 500mg powder for solution for injection vialsImported (United States)
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Austria · Brietal
- Germany · Brevimytal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8cd7d7e3-c014-4552-8246-1f3a60e2220d GET /v1/drugs/8cd7d7e3-c014-4552-8246-1f3a60e2220d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h00544_smpc.pdf",
"strength": null,
"atc_label": "Methohexital",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg00544",
"excipients": [
"NATRIUMCARBONAAT 1-WATER (E 500 (I))",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"METHOHEXITAL NATRIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h00544.pdf",
"authorised_at": "1990/02/19",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "00544",
"additional_monitoring": "N"
}See everything about methohexital.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.